JAVELIN PHARMACEUTICALS

javelin-pharmaceuticals-logo

Javelin Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and commercialization of products for the pain management market primarily in the United States and Europe. Its products focus on treating various pain disorders ranging from acute and episodic moderate-to-severe pain associated with breakthrough cancer pain, post-operative pain, post-trauma pain (orthopedic injury pain), procedural pain, and burn pain. The company's Dyloject (injectable dicl... ofenac) received approval for marketing to treat post-operative pain in the United Kingdom and was licensed to Therabel Pharma N.V. for commercialization in the European Union and certain other countries outside the United States. Its products in the Phase 3 development stage in the U.S. include Dyloject (diclofenac sodium injectable), an injectable formulation of diclofenac and a prescription nonsteroidal anti-inflammatory drug that is used to treat post-operative pain due to its combination of effectiveness and tolerability; Ereska (intranasal ketamine), a proprietary nasal formulation; and Rylomine (intranasal morphine) for treatment of acute moderate-to-severe pain, including breakthrough pain. Javelin Pharmaceuticals has license agreements with Shimoda Biotech, Ltd. to develop and commercialize products related to a proprietary formulation of the injectable delivery of diclofenac; and West Pharmaceutical Services, Inc. to develop and commercialize intranasal morphine for the transmucosal delivery of morphine to humans and animals for the treatment of pain. The company was founded in 1998 and is based in Cambridge, Massachusetts.

#SimilarOrganizations #People #Financial #Website #More

JAVELIN PHARMACEUTICALS

Industry:
Biotechnology Developer Platform Pharmaceutical

Founded:
1998-01-01

Address:
Cambridge, Massachusetts, United States

Country:
United States

Website Url:
http://www.javelinpharmaceuticals.com

Total Employee:
11+

Status:
Active

Contact:
617-349-4500

Email Addresses:
[email protected]

Total Funding:
32.75 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon WordPress Content Delivery Network Font Awesome Mobile Non Scaleable Content Euro Yoast WordPress SEO Plugin


Similar Organizations

cydex-pharmaceuticals-logo

CyDex Pharmaceuticals

CyDex Pharmaceuticals is a pharmaceutical company that engages in the development and commercialization of drugs specifically designed.

Current Employees Featured

not_available_image

Martin J. Driscoll
Martin J. Driscoll CEO @ Javelin Pharmaceuticals
CEO

fred-mermelstein_image

Fred Mermelstein
Fred Mermelstein Director and Founder @ Javelin Pharmaceuticals
Director and Founder
2009-01-01

not_available_image

Stephen J. Tulipano
Stephen J. Tulipano CFO @ Javelin Pharmaceuticals
CFO

Founder


fred-mermelstein_image

Fred Mermelstein

Investors List

national-cancer-institute_image

National Cancer Institute

National Cancer Institute investment in Grant - Javelin Pharmaceuticals

ngn-capital_image

NGN Capital

NGN Capital investment in Private Equity Round - Javelin Pharmaceuticals

wexford-capital_image

Wexford Capital

Wexford Capital investment in Private Equity Round - Javelin Pharmaceuticals

Official Site Inspections

http://www.javelinpharmaceuticals.com

  • Host name: ip234.ip-94-23-115.eu
  • IP address: 94.23.115.234
  • Location: Germany
  • Latitude: 51.2993
  • Longitude: 9.491
  • Timezone: Europe/Berlin

Loading ...

More informations about "Javelin Pharmaceuticals"

Javelin Pharmaceuticals - Crunchbase Company Profile …

Javelin Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and commercialization of products for the pain management market primarily in the United States and Europe.See details»

Javelin Pharmaceuticals - Overview, News & Similar companies

Who is Javelin Pharmaceuticals. Javelin Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and commercialization of products for the …See details»

Javelin Pharmaceuticals, Inc. - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Javelin Pharmaceuticals, Inc. of Lake Forest, IL. Get the latest business insights from Dun & Bradstreet.See details»

Javelin Pharmaceuticals - PitchBook

Javelin Pharmaceuticals General Information Description. Developer and researcher of treatments for the relief of severe pain. The company applies proprietary technologies to develop new …See details»

Javelin Pharmaceuticals Inc - Company Profile and News

Company profile page for Javelin Pharmaceuticals Inc including stock price, company news, executives, board members, and contact informationSee details»

Javelin Pharmaceuticals - Products, Competitors, Financials, …

Javelin is a specialty pharmaceutical company that applies innovative proprietary technologies to develop new drugs and improved formulations of existing drugs that target current unmet and …See details»

Hospira and Javelin Pharmaceuticals Enter Into Definitive Merger ...

Apr 19, 2010 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a global specialty pharmaceutical and medication delivery company, and Javelin Pharmaceuticals, Inc. (NYSE...See details»

Hospira, Inc. and Javelin Pharmaceuticals Enter Into ... - BioSpace

Apr 19, 2010 Hospira, Inc. and Javelin Pharmaceuticals Enter Into Definitive Merger Agreement for Hospira to Acquire Javelin for Approximately $145 Million - read this article along with other …See details»

Javelin Pharmaceuticals - VentureRadar

Javelin Pharmaceuticals VentureRadar profile. Find out more about Javelin Pharmaceuticals including the VentureRadar Innovation and Growth scores, Similar Companies and more.See details»

Javelin Pharmaceuticals, Inc. (Javelin Pharmaceuticals, Inc.) - 药物 …

An Open-Label, Single-Dose Study to Evaluate the Safety and Pharmacokinetics of DIC075V in Subjects With Mild or Moderate Chronic Renal Insufficiency and in Subjects With Mild Chronic …See details»

Massachusetts' Top 19 Pharmaceutical Manufacturing Entities

Industry Pharmacist Organization (IPhO) is a professional organization recognized within the pharmaceutical industry for equipping pharmacist members with the skills to contribute to the …See details»

Javelin Pharmaceuticals Announces 15 Percent Reduction in …

Nov 14, 2008 Javelin Pharmaceuticals Announces 15 Percent Reduction in Workforce CAMBRIDGE, Mass. -- Javelin Pharmaceuticals, Inc. (Amex: JAV - News), a leading …See details»

Javelin Pharmaceuticals - Pharma news, views and analysis

Oct 15, 2021 Pharma news, views and analysis. Dianabol has been one of the most popular steroids for performance enhancement ever produced, and its usage has been paramount …See details»

Javelin Pharmaceut. : Javelin Pharmaceuticals Announces …

Jun 19, 2007 Javelin Pharmaceuticals, Inc. Investor Relations & Media Rick Pierce, 617-349-4500 VP Investor Relations [email protected] or Corporate …See details»

Javelin Pharmaceuticals Inc. - The New York Times

News about Javelin Pharmaceuticals Inc., including commentary and archival articles published in The New York Times.See details»

Placebo-controlled Study of Intranasl Ketamine for Breakthrough …

Results from this randomized, double-blind, placebo-controlled crossover study, published as a lead article in the peer-reviewed journal of the International Association for the Study of Pain …See details»

Javelin Biotech

Drug Discovery. Humanized. Javelin Biotech creates predictive drug discovery platforms that merge human biology with computational biology to accelerate preclinical drug discovery and …See details»

Javelin Pharmaceuticals's Positive Rylomine(TM) Phase II

May 4, 2006 CONTACT: June Gregg of Javelin Pharmaceuticals, Inc., +1-212-554-4550,[email protected]; or Bryan P. Murphy of LaVoie Group,+1-781-596 …See details»

What Lies Ahead for Javelin Pharmaceuticals? - Seeking Alpha

Javelin Pharmaceuticals (JAV) is a specialty pharmaceutical company with a focus in the pain management market. Their primary technical innovations are improved formulations of existing …See details»

Javelin Pharmaceuticals Reports Ereska (Intranasal ... - Fierce Biotech

Aug 11, 2009 Javelin Pharmaceuticals Reports Ereska (Intranasal Ketamine) Phase III Trial Results in Postoperative Orthopedic Pain CAMBRIDGE, Mass.--(BUSINESS WIRE)--Javelin …See details»

linkstock.net © 2022. All rights reserved